About Us
- About Us
-
Hallym University College of Medicine, South Korea Prof. Jin Pyeong Jeon MD. Ph.D Director in The FirstKSGAR
Dr. Jin Pyeong Jeon is an associate professor in the Department of Neurosurgery, Hallym University College of
Medicine, Chuncheon, South Korea. He has trained in cerebrovascular neurosurgery, endovascular intervention
and neuro-intensive care. He performs clinical and laboratory studies in stroke, particularly acute ischemic
stroke and subarachnoid hemorrhage. He has published research on genetic determinants of aneurysm
formation and the role of haptoglobin genotype on clinical outcome after subarachnoid haemorrhage. In
addition, he is actively working on employing artificial intelligence and oriental medicine in the diagnosis and
treatment of stroke. -
Hallym University College of Medicine, South Korea Dr. Eun Pyo Hong Ph.D Senior Manager in The FirstKSGAR
Dr. Eunpyo Hong is a senior scientist in the Institute of New Frontier Research, Hallym University, Chuncheon,
South Korea. Research Fellow in Harvard Medical School and Broad Institute (2018-2021, Boston MA USA).
He has trained strongly Genetic Epidemiology and Bioinformatics/Biostatistics to identify genetic
modifications and its mechanisms while evaluating a risk prediction on human complex diseases such as
cardiovascular diseases (e.g., stroke and its subtypes), using a large-scale GWAS and meta-analysis,
whole-genome/exome/transcriptome sequencing technique. He handles subsequently a various
programming language of Python, Perl, and R. He recently investigates disease susceptibility loci and develops
disease risk prediction models on human complex and clinical outcomes, especially, subarachnoid
hemorrhage and intracranial aneurysm. -
Hallym University Pyeongchon Sacred Heart Hospital, South Korea Prof. In Bok Chang MD. Ph.D
Dr. In Bok Chang is a professor in the Department of Neurosurgery, Hallym University Pyeongchon Sacred
Heart Hospital, Anyang, South Korea. He has trained in cerebrovascular neurosurgery and endovascular
intervention. He performs clinical and laboratory studies in stroke and traumatic brain injury. He is interested
in research of genetic studies of stroke development and cognitive impairment using GWAS, WES, and
epigenetics and actively working on employing artificial intelligence and treatment of stroke. -
CHA University College of Medicine, South Korea Prof. Seung Hun Sheen MD. Ph.D
Dr. Seung Hun Sheen is a professor in the Department of Neurosurgery, CHA University College of Medicine,
Sungnam, South Korea. He is currently the president of the Acute Stroke Treatment Research Organization.
He is trained in cerebrovascular surgery, endovascular neurosurgery and skull base neurosurgery. He performs
clinical and laboratory studies in stroke and traumatic brain injury. He has published research on clinical
studies of stroke development. In addition to, he is actively working on the systems of care for critical &
emergent stroke. -
Jeju National University College of Medicine, South Korea Prof. Jong Kook Rhim MD. Ph.D
Dr. Jong-Kook Rhim is an associate professor in the Department of Neurosurgery, Jeju National University,
College of Medicine, Jeju Self-Governing Province, South Korea. He has trained in cerebrovascular
neurosurgery and neuroendovascular intervention. He performs clinical and laboratory studies in stroke and
traumatic brain injury. He has published research on genetic and clinical studies of stroke. He is also actively
working on hemorrhagic and ischemic stroke management in regional cardiocerebrovascular center of Jeju
National University Hospital. -
Dankook University College of Science & Technology, South Korea Prof. Keunsoo Kang Ph.D
Dr. Keun Soo Kang is a computational biologist (Ph.D. in Bioinformatics) who conducts data-driven research
using bioinformatics and artificial intelligence technologies. Over the past 15 years, he has published over 100
next-generation sequencing-based papers in peer-reviewed journals. Currently, my research is focused on the
development of deep learning-based applications that can elegantly solve complex problems. In this regard,
he recently published the world's first deep learning-based drug replacement prediction paper for COVID-19. -
Kangwon National University College of Medicine, South Korea Prof. Jun Hyong Ahn MD. Ph.D
Dr. Jun Hyong Ahn is an associate professor in the Department of Neurosurgery, Kangwon National University
College of Medicine, Chuncheon, South Korea. He is a board-certified neurosurgeon and completed fellowship
in cerebrovascular surgery and endovascular intervention. He specializes in treating patients with
cerebrovauscular disease and traumatic brain injury. His research interests include clinical and laboratory
studies in patients with subarachnoid hemorrhage and acute ischemic stroke. -
Kangdong Sacred Heart Hospital, South Korea Prof. Hong Jun Jeon MD. Ph.D
Dr. Hong Jun Jeon is an associate professor in the Department of Neurosurgery at the Kangdong Sacred Heart Hospital, Hallym University College of Medicine. He is a director of a scientific committee of the Korean Society of Interventional Neuroradiology. He has specialized in the combined approach from microsurgery and neurointervention at the cerebrovascular field via the hybrid operative system. He has shown excellent clinical results in hemorrhagic and ischemic cerebrovascular diseases.
-
Department of Genomic Medicine, Seoul National University Hospital, South Korea Prof. Sungyoung Lee Ph.D
Dr. Sungyoung Lee is a professor actively implementing clinical application of precision medicine at Seoul
National University Hospital and conducting various researches including statistical analysis of large-scale
clinical genome, bio big-data analysis using machine learning techniques, and interactive visualization of
multi-omics data. -
Gachon University College of Medicine, South Korea Prof. Chan Jong Yoo MD. Ph.D
Dr. Chan Jong Yoo is a professor in the Department of Neurosurgery, Gachon University College of Medicine,
Inchon, South Korea. He has trained in cerebrovascular neurosurgery, endovascular intervention and
neuro-intensive care. He is the director of the Neuroscience Institute in the Gachon Medical school. He has
investigated neural stem cell and gene therapy for degenerative neurological diseases and spinal diseases. -
Inha University College of Medicine, South Korea Prof. Dong Keun Hyun MD. Ph.D
Dr. Hyun Dong Keun is a professor in the Department of Neurosurgery, Inha University Hospital, Incheon,
South Korea. He was trained in Cerebrovascular, intervention, Neurotrauma and intensive care. He’s interesting
research fields were Neurotrauma and stroke and recently genetic study. -
Konkuk University Medical Center, South Korea Prof. Jeong Jin Park MD. Ph.D
Dr. Jeong Jin Park is an associate professor in the Department of Neurology at Konkuk University Medical
Center in Seoul, South Korea. He undertook the stroke neurology training at Konkuk University in 2016 and
neuro-intervention training at Seoul National University (2014) and Samsung Medical Center (2015).He has a
strong interest in the neuro-interventional radiology, neuro-critical care and mechanism of the stroke disease.
He has published research on genetic studies of stroke development and stroke treatment. In addition, he is
actively working on employing new modality in neuro-critical care and treatment of stroke. -
Kyung Hee university College of Medicine, South Korea Prof. Seungwon Kwon
Dr. Seungwon Kwon is an associate professor in the Department of Cardiology and Neurology, College of
Medicine, Kyung Hee University, Seoul, South Korea. He has trained in neurology, and traditional
Korean medicine (TKM). He performs clinical studies in cerebrovascular diseases (stroke) and movement
disorders. He has published research on clinical studies of neurological diseases treatment using traditional
herbal medicine and acupuncture. In addition, he is researching with interest in the polypharmacy
(multi-drug use) of elderly patients with neurological diseases. -
Hallym University College of Medicine, South Korea Dr. Bong Jun Kim Ph.D
Dr. Bong Jun Kim am a PhD researcher in the Institute of New Frontier Research, Hallym University,
Chuncheon, South Korea. He performs bioinformatics analysis (in silico), animal testing (in vivo), and basic
science experiments (in vitro). Through the above method, he has published several translational scientific
papers, targeting neurosurgical diseases such as cerebral hemorrhage and cerebral infarction. Recently, he is
developing a patient classification method through deep learning with genomic information. -
Hallym University College of Medicine, South Korea Dong Hyuk Youn, Ph.D.
Dong Hyuk Youn is a research fellow. in the Institute of New Frontier Research, Hallym University, Chuncheon,
South Korea. He has trained in surgery guidance for neurosurgical rodent models of various cerebrovascular
diseases such as subarachnoid hemorrhage, Intracerebral hemorrhage, ischemic stroke, dementia,
and traumatic brain injury. He performs laboratory works in specific stroke types including acute ischemic
stroke using patient samples with blood, CSF, plasma, and so on. He has investigated a genetic determinants
of delayed cerebral ischemia and identified the role of mitochondrial dysfunction after subarachnoid
hemorrhage. In addition, he is recently working on the identification of the mitochondrial dysfunction in Moyamoya disease. -
University of Southampton, Southampton General Hospital, UK Prof. Ian Galea MD, PhD, FRCP
Prof. Ian Galea is a Consultant Neurologist and Professor in Clinical & Experimental Neurology in Southampton.
He leads a multidisciplinary group of investigators studying inflammatory and haemorrhagic brain conditions,
funded by grants from Research Councils, charities and pharmaceutical companies in the UK. Seminal
contributions to the field include studies of the CD163-haptoglobin and CD91-haemopexin scavenging systems
in the human brain, and development of a subarachnoid haemorrhage specific outcome tool. Expertise spans
clinical and preclinical domains, including clinical outcome prediction, assessment, neuro- imaging, cell
culture, immunochemistry, molecular techniques and preclinical modelling. A main focus is to turn basic
science discoveries into clinically applicable tools and therapies. -
University of Southampton, Southampton General Hospital NHS Trust, UK Mr. Ben Gaastra
Mr. Ben Gaastra graduated from The University of Cambridge in 2013 and became a member of The Royal
College of Surgeons in 2016. Mr Gaastra then entered the Academic Foundation Programme in neurosciences
(King’s College Hospital, London) during which he trained under Professor Al-Chalabi in bioinformatic and
genetic analysis. Mr Gaastra commenced neurosurgical training at University Hospital Southampton. He has
completed a meta-analysis of haptoglobin genotype and outcome after subarachnoid haemorrhage. As part
of the consortium Mr Gaastra has published a review of haemoglobin scavenging in the brain and has led an
individual patient level data analysis of haptoglobin genotype and outcome after subarachnoid haemorrhage.